Tretinoin Enhances the Effects of Chemotherapy in Juvenile Myelomonocytic Leukemia Using an Ex Vivo Drug Sensitivity Assay is a research paper published in JCO Precision Oncology (2023). On theSindex it has a DataRank of 0.253. It has been cited 4 times, with 3 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.241
From this paper's citation signal
Citation Network Contribution
0.0120
From 1 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 3 citers.
NCI NIH HHS
Grant: R37 CA266550
NCI NIH HHS
Grant: U54 CA196519
National Institutes of Health
Grant: 5R37CA266550-03
Implementation of an interventional, risk-adapted clinical trial for children with newly diagnosed juvenile myelomonocytic leukemia.
National Institutes of Health
Grant: 5U54CA196519-05
Developmental and HyperActive Ras Tumor SPORE
Fields of Study
MeSH Terms
Keywords